Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 5;77(Suppl 1):S46-S52.
doi: 10.1093/cid/ciad263.

Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital

Matias C Salomão  1   2 , Maristela P Freire  1   2 , Carolina S Lázari  3 , Ana P Cury  4 , Flávia Rossi  4 , Aluisio A C Segurado  1   5 , Silvia F Costa  1   2   5 , Anna S Levin  1   2   5 , Ícaro Boszczowski  1   2 ; Carbapenem Resistant Enterobacterales in Emergency Department (CRE-ED) Task Force
Collaborators, Affiliations

Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital

Matias C Salomão et al. Clin Infect Dis. .

Erratum in

Abstract

Background: Overcrowded emergency departments (EDs) may increase the risk of carbapenem-resistant Enterobacterales (CRE) transmission.

Methods: We conducted a quasi-experimental study divided into 2 phases (baseline and intervention) to investigate the impact of an intervention on the acquisition rate and identify risk factors for CRE colonization in an ED of a tertiary academic hospital in Brazil. In both phases, we did universal screening with rapid molecular test (blaKPC, blaNDM, blaOXA48, blaOXA23, and blaIMP) and culture. At baseline, both screening test results were not reported, and patients were put under contact precautions (CP) based on previous colonization or infection by multidrug-resistant organisms. During the intervention, all patients hospitalized in the ED were placed in empiric CP and the result of CRE screening was reported; if negative, patients were released from CP. Patients were rescreened if they stayed >7 days in the ED or were transferred to an intensive care unit.

Results: A total of 845 patients were included: 342 in baseline and 503 in intervention. Colonization at admission was 3.4% by culture and molecular test. Acquisition rates during ED stay dropped from 4.6% (11/241) to 1% (5/416) during intervention (P = .06). The aggregated antimicrobial use in the ED decreased from phase 1 to phase 2 (804 defined daily doses [DDD]/1000 patients to 394 DDD/1000 patients, respectively). Length of stay >2 days in the ED was a risk factor for CRE acquisition (adjusted odds ratio, 4.58 [95% confidence interval, 1.44-14.58]; P = .01).

Conclusions: Early empiric CP and rapid identification of CRE-colonized patients reduce cross-transmission in ED. Nevertheless, staying >2 days in ED compromised efforts.

Keywords: PCR; carbapenem-resistant Enterobacterales; emergency department; multidrug resistance; screening.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. M. C. S. received research funding from FAPESP, CDC, and JHPiego; grants from Cepheid as a speaker; and holds stocks with Petrobras and Vale do Rio Doce. I. B. received funding from FAPESP to support this study and additional funding from the CDC and JHPiego. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

    1. World Health Organization (WHO) . Antimicrobial resistance global report on surveillance. Geneva, Switzerland: WHO, 2014.
    1. Stewardson A, Fankhauser C, De Angelis G, et al. . Burden of bloodstream infection caused by extended-spectrum β-lactamase–producing Enterobacteriaceae determined using multistate modeling at a Swiss university hospital and a nationwide predictive model. Infect Control Hosp Epidemiol 2013; 34:133–43. - PubMed
    1. Swaminathan M, Sharma S, Poliansky Blash S, et al. . Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013; 34:809–17. - PubMed
    1. Yigit H, Queenan AM, Anderson GJ, et al. . Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151–61. - PMC - PubMed
    1. Kumarasamy KK, Toleman MA, Walsh TR, et al. . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597–602. - PMC - PubMed

Publication types

MeSH terms